Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 15918 | 683 | 28.4 | 41% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
| 4008 | 2 | DIHYDRALAZINE SULFATE//DRUG INDUCED LUPUS//HYDRALAZINE HYDROCHLORIDE | 683 |
| 15918 | 1 | DIHYDRALAZINE SULFATE//DRUG INDUCED LUPUS//HYDRALAZINE HYDROCHLORIDE | 683 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DIHYDRALAZINE SULFATE | authKW | 143059 | 1% | 80% | 4 |
| 2 | DRUG INDUCED LUPUS | authKW | 139545 | 2% | 20% | 16 |
| 3 | HYDRALAZINE HYDROCHLORIDE | authKW | 111761 | 1% | 50% | 5 |
| 4 | HYDRALAZINE | authKW | 65288 | 3% | 6% | 23 |
| 5 | MOL EXPT MED WM KECK AUTOIMMUNE DIS | address | 59607 | 0% | 67% | 2 |
| 6 | PROCAINAMIDE | authKW | 55786 | 2% | 9% | 14 |
| 7 | DRUG RELATED LUPUS | authKW | 55018 | 1% | 31% | 4 |
| 8 | 1 4 DITHIOTHREITOL DTT AS STABILIZER | authKW | 44706 | 0% | 100% | 1 |
| 9 | 2 HYDROXY 1 NAPHTHALDEHYDE DERIVATIZATION | authKW | 44706 | 0% | 100% | 1 |
| 10 | 2 PHENYLETHYL HYDRAZINE | authKW | 44706 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2078 | 33% | 0% | 227 |
| 2 | Rheumatology | 1310 | 8% | 0% | 56 |
| 3 | Toxicology | 1129 | 13% | 0% | 87 |
| 4 | Medicine, General & Internal | 458 | 13% | 0% | 91 |
| 5 | Chemistry, Medicinal | 312 | 7% | 0% | 48 |
| 6 | Chemistry, Analytical | 85 | 6% | 0% | 43 |
| 7 | Oncology | 36 | 6% | 0% | 41 |
| 8 | Pathology | 31 | 3% | 0% | 18 |
| 9 | Medicine, Research & Experimental | 26 | 4% | 0% | 24 |
| 10 | Biochemistry & Molecular Biology | 23 | 10% | 0% | 67 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MOL EXPT MED WM KECK AUTOIMMUNE DIS | 59607 | 0% | 67% | 2 |
| 2 | AGA EPILEPSY NEUROL | 44706 | 0% | 100% | 1 |
| 3 | BURNABY HOSP PHARM | 44706 | 0% | 100% | 1 |
| 4 | CIDAT SA CV | 44706 | 0% | 100% | 1 |
| 5 | CLIN CHEM TOXICOL SECT | 44706 | 0% | 100% | 1 |
| 6 | KECK AUTOIMMUNE DIS | 44706 | 0% | 100% | 1 |
| 7 | MCCSHAE | 44706 | 0% | 100% | 1 |
| 8 | MECHANIST TARGET BIOL | 44706 | 0% | 100% | 1 |
| 9 | MED 111 1660 S COLUMBIAN WAY | 44706 | 0% | 100% | 1 |
| 10 | MED KUNIK | 44706 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | REVUE ROUMAINE DE BIOCHIMIE | 17773 | 2% | 4% | 11 |
| 2 | EXPERIMENTAL PATHOLOGY | 3861 | 1% | 1% | 8 |
| 3 | JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS REVIEWS | 3724 | 0% | 8% | 1 |
| 4 | ARTHRITIS AND RHEUMATISM | 2079 | 3% | 0% | 22 |
| 5 | DRUG METABOLISM AND DISPOSITION | 1903 | 3% | 0% | 18 |
| 6 | REVIEWS IN BIOCHEMICAL TOXICOLOGY | 1861 | 0% | 4% | 1 |
| 7 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1772 | 1% | 0% | 9 |
| 8 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1483 | 2% | 0% | 14 |
| 9 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1400 | 2% | 0% | 15 |
| 10 | CHEMICAL RESEARCH IN TOXICOLOGY | 1219 | 2% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | YUNG, RL , RICHARDSON, BC , (1994) DRUG-INDUCED LUPUS.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 20. ISSUE 1. P. 61 -86 | 64 | 41% | 129 |
| 2 | MATHISON, BH , MURPHY, SE , SHANK, RC , (1994) HYDRALAZINE AND OTHER HYDRAZINE DERIVATIVES AND THE FORMATION OF DNA-ADDUCTS.TOXICOLOGY AND APPLIED PHARMACOLOGY. VOL. 127. ISSUE 1. P. 91-98 | 22 | 85% | 17 |
| 3 | SOLINGER, AM , (1988) DRUG-RELATED LUPUS - CLINICAL AND ETIOLOGIC CONSIDERATIONS.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 14. ISSUE 1. P. 187-202 | 41 | 56% | 38 |
| 4 | KROHN, K , BENNETT, R , (1998) DRUG-INDUCED AUTOIMMUNE DISORDERS.IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. VOL. 18. ISSUE 4. P. 897 -+ | 34 | 46% | 5 |
| 5 | HESS, EV , MONGEY, AB , (1991) DRUG-RELATED LUPUS.BULLETIN ON THE RHEUMATIC DISEASES. VOL. 40. ISSUE 4. P. 1-8 | 28 | 72% | 18 |
| 6 | RUBIN, RL , (2015) DRUG-INDUCED LUPUS.EXPERT OPINION ON DRUG SAFETY. VOL. 14. ISSUE 3. P. 361 -378 | 24 | 32% | 12 |
| 7 | MONGEY, AB , HESS, E , (2001) IN VITRO PRODUCTION OF ANTIBODIES TO HISTONES IN PATIENTS RECEIVING CHRONIC PROCAINAMIDE THERAPY.JOURNAL OF RHEUMATOLOGY. VOL. 28. ISSUE 9. P. 1992-1998 | 16 | 80% | 2 |
| 8 | HOFSTRA, AH , (1994) METABOLISM OF HYDRALAZINE - RELEVANCE TO DRUG-INDUCED LUPUS.DRUG METABOLISM REVIEWS. VOL. 26. ISSUE 3. P. 485-505 | 31 | 51% | 9 |
| 9 | HARDEE, JT , ROLDAN, CA , DUCLOS, TW , (1997) BETAXOLOL AND DRUG-INDUCED LUPUS COMPLICATED BY PERICARDITIS AND LARGE PERICARDIAL EFFUSION.WESTERN JOURNAL OF MEDICINE. VOL. 167. ISSUE 2. P. 106-109 | 14 | 82% | 4 |
| 10 | PREISS, R , BAUMANN, F , REGENTHAL, R , MATTHIAS, M , (2006) PLASMA KINETICS OF PROCARBAZINE AND AZO-PROCARBAZINE IN HUMANS.ANTI-CANCER DRUGS. VOL. 17. ISSUE 1. P. 75-80 | 12 | 71% | 6 |
Classes with closest relation at Level 1 |